Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Child-Pugh aknas aknu cirozes gadījumā× | Hārvija-Bredšova indekss× | |
|---|---|---|
| Nozare | Gastroenteroloģija | Gastroenteroloģija |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1964 (Child-Turcotte), 1973 (Pugh modification) | 1980 |
| Autors≠ | Child, C. G., Turcotte, J. G., and Pugh, R. N. | R. F. Harvey and J. M. Bradshaw |
| Tips | Clinician-rated | Clinician-rated |
| Pirmavots≠ | Child, C. G., & Turcotte, J. G. (1964). Surgery and portal hypertension. In C. G. Child (Ed.), The liver and portal hypertension (pp. 50–64). Saunders. link ↗ | Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514. DOI ↗ |
| Citi nosaukumi≠ | Child-Turcotte-Pugh Score, CTP Score | HBI |
| Saistītās≠ | 4 | 5 |
| Kopsavilkums≠ | The Child-Pugh Score (originally Child-Turcotte, modified by Pugh in 1973) is a clinical scoring system that stratifies the severity of liver cirrhosis and predicts surgical mortality and prognosis. The score integrates five readily available clinical and laboratory parameters: bilirubin, albumin, prothrombin time (INR), ascites, and hepatic encephalopathy. With a total range of 5–15 points, the Child-Pugh Score is stratified into Class A (mild, 5–6 points), Class B (moderate, 7–9 points), and Class C (severe, 10–15 points), each with distinct mortality predictions. | The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response. |
| ScholarGateDatu kopa ↗ |
|
|